HIV, lenacapavir and Data
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...
HIV prevention medication ‘could one day be a yearly jab’ – study suggests - Yearly doses could reduce barriers people face ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results